World Pharma Today

Sunday, Mar 01st

Last update:12:00:00 AM GMT

Headlines:
RSS
You are here: Home
Washington University-developed new breast cancer vaccine shows promise

Washington University-developed new breast cancer vaccine shows promise

Researchers at Washington University School of Medicine in St. Louis, US, have reported preliminary data from a small clinical trial of a new breast cancer vaccine.

Add new comment
Read more...
Pfizer establishes gene therapy unit for rare disease research

Pfizer establishes gene therapy unit for rare disease research

Researchers at Washington University School of Medicine in St. Louis, US, have reported preliminary data from a small clinical trial of a new breast cancer vaccine.

Add new comment
Read more...
Scientists at Oxford University begin first booster Ebola vaccine trials

Scientists at Oxford University begin first booster Ebola vaccine trials

Scientists at Oxford University have started first booster Ebola vaccine trials to test its safety and evaluate its potential to further increase the immune responses seen in healthy volunteers.

Add new comment
Read more...
Daiichi and UCB Biopharma partner to introduce epilepsy treatment Lacosamide in Japan

Daiichi and UCB Biopharma partner to introduce epilepsy treatment Lacosamide in Japan

Japan-based Daiichi Sankyo has signed an agreement with UCB Biopharma to jointly commercialise Lacosamide for the treatment of patients with epilepsy in Japan.

Add new comment
Read more...
Mylan and Gilead partner for TAF-based HIV treatments in developing markets

Mylan and Gilead partner for TAF-based HIV treatments in developing markets

Mylan Laboratories has signed an agreement with Gilead Sciences to increase access to Tenofovir Alafenamide (TAF) based HIV treatments in developing countries....

AstraZeneca (AZ) and Eli Lilly have started AMARANTH, a phase II/III study investigating a potential treatment for early Alzheimer's disease.

AstraZeneca (AZ) and Eli Lilly have started AMARANTH, a phase II/III study investigating a potential treatment for early Alzheimer's disease.

The trial will examine oral beta secretase cleaving enzyme (BACE) inhibitor AZD3293, also known as LY3314814, which reduced levels of amyloid-beta in the cereb...

EFPIA hails joint action on counterfeit drugs

EFPIA hails joint action on counterfeit drugs

The pan-European medicines verification system uses an anti-tampering device together with 2D barcoding to verify the authenticity of medicinal products and is...

Banner

Knowledge Bank

Edit

Amount of short articles:

Amount of articles links:

You can order sections with dragging on list bellow:

  • Knowledge Bank
  • Business & Industry
Save
Cancel
Reset

News

Lilly Provides Update on Evacetrapib Phase 3

INDIANAPOLIS, Feb. 19, 2015 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) has accepted the recommendation of the ACCELERATE study academic executive committee, based on emerging science in the cardiovascular

Thursday, 19 February 2015 Comments

Press Releases

Orion Pharma Animal Health and Vetoquinol Enter Distribution Collaboration from 1 January

Orion Pharma Animal Health and Vetoquinol have announced their collaboration regarding the distribution of Orion's sedatives product family alpha-2 agonists and antagonist Dexdomitor, Domitor and Domosedan and

Tuesday, 17 February 2015 Comments

Research Insight

Amgen and Kite Pharma to develop CAR T cell

US-based Amgen has signed a strategic research collaboration and license agreement with Kite Pharma to develop and commercialise chimeric antigen receptor (CAR) T cell

Tuesday, 6 January 2015 Comments

Techno Trends

Ireland’s Shire to acquire NPS Pharmaceuticals for

Irish drugmaker Shire has signed a merger agreement to acquire US-based NPS Pharmaceuticals for

Tuesday, 13 January 2015 Comments

Industry Reports

Seattle Genetics, BMS to evaluate Adcetris and Opdivo

Seattle Genetics and Bristol-Myers Squibb (BMS) have entered into a clinical trial collaboration agreement to evaluate the investigational combination of Adcetris and Opdivo in two planned Phase I/II clinical

Wednesday, 14 January 2015 Comments

Articles

Why streamlining pharma supply chain is

For most pharmaceuticals executives, the prospect of the patent cliff is looming large in their thoughts. But an additional – and less obvious – challenge is also ready to derail

Wednesday, 18 July 2012 Comments

Business & Industry

Edit

Amount of short articles:

Amount of articles links:

You can order sections with dragging on list bellow:

  • Knowledge Bank
  • Business & Industry
Save
Cancel
Reset

Drug Research

Sanofi, Fraunhofer create new natural product center of

French pharmaceutical firm Sanofi and Germany-based Fraunhofer-Gesellschaft have formed a natural product center of excellence to speed up the discovery and development of new therapies to treat infectious

Friday, 17 January 2014 Comments

Production & Manufacturing

Galena Biopharma Acquires Mills

Galena Biopharma, a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, announced it has acquired Mills Pharmaceuticals, which has

Thursday, 16 January 2014 Comments

Packaging & Labelling

Canada unveils new labeling initiative to enhance drug

Canada has rolled out the plain language labeling initiative to improve the safe use of medicines by making drug labels and safety information easier to read and understand for all

Monday, 17 June 2013 Comments

Strategy

OncoMed Pharmaceuticals and Bayer HealthCare Expand Cancer Stem Cell Collaboration with Clinical Manufacturing

OncoMed Pharmaceuticals, Inc., a company developing novel therapeutics targeting cancer stem cells, today announced it has expanded its collaboration with Bayer HealthCare. Bayer’s U.S. affiliate will manufacture clinical supplies of

Saturday, 21 July 2012 Comments

Clinical Trials

Enox Biopharma, LTD. Announces First Enrollments of A Phase 1a/lb Clinical

Enox Biopharma, Ltd., a leader in nitric oxide delivery technology for the prevention of hospital acquired infections announced today the enrollment of the first subjects in a phase 1a/1b study

Friday, 9 January 2015 Comments

IT & Data Management

Pharma Security Group introduces new medication reminder

Pharma Security Group (PSG) has introduced a new medication reminder service, myPharmaCall, designed for users to set up daily phone call reminders for their

Thursday, 22 August 2013 Comments

Banner